Could a drink protect eyesight in glaucoma?
NCT ID NCT06333236
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 33 times
Summary
This study tested whether a daily oral solution containing citicoline and nicotinamide (Kron®) could improve eye function in 30 people with moderate open-angle glaucoma. Participants had controlled eye pressure but still had vision loss. The study measured electrical activity in the retina and brain, as well as visual field tests, over a short period. The goal was to see if the supplement could help protect remaining vision, not to cure the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
ASST Santi Paolo e Carlo
Milan, Mi, 20142, Italy
-
Luca Rossetti
Milan, MI, 20142, Italy
Conditions
Explore the condition pages connected to this study.